Keywords:
Genital / Reproductive system male, Pelvis, MR, MR-Diffusion/Perfusion, MR-Spectroscopy, Observer performance, Outcomes analysis, Structured reporting, Cancer
Authors:
D. Gutierrez, O. Chirife, C. Pineda; Barcelona/ES
DOI:
10.1594/ecr2013/C-0968
References
1.
Ferlay J,
Shin HR,
Bray F,
Forman D,
Mathers C,
Parkin DM.
GLOBOCAN 2008 v1.2,
Cancer Incidence and Mortality Worldwide: IARC CancerBase No.
10 [Internet] Lyon,
France: International Agency for Research on Cancer,
2010.
Available from: http://globocan.iarc.fr.
2.
Rosenkrantz AB et al.3.0 T multiparametric prostate MRI using pelvic phased-array coil: Utility for tumor detection prior to biopsy.
Urol Oncol. 2012 Mar 29.
3.
Portalez D et al.
Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol.
(2012)
4.
Fütterer JJ et al.
Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
Radiology. 2006 Nov;241(2):449-58.
Epub 2006 Sep 11.
5.
Jelle O.
Barentsz, Jonathan Richenberg et al.
ESUR prostate MR guidelines 2012.
Eur Radiol (2012) 22:746–757
6.
Baris Turkbey et al.
Prostate Cancer: Value of Multiparametric MR Imaging at 3 T for Detection—Histopathologic Correlation.
Radiology. 2010 April; 255(1): 89–99.